MSNBC Reports: "Four out of five doctors surveyed said they let drug and device makers buy them food and drinks despite recent efforts to tighten ethics rules and avoid conflicts of interest."
Read the full article and watch the video aired at:
http://www.msnbc.msn.com/id/18311856/
"The study is the first to document the extent of the relationships between doctors and sales reps since 2002 when a leading industry group adopted voluntary guidelines discouraging companies from giving doctors gifts or tickets. In general, researchers found hardly anything had changed since previous studies a couple years earlier."
All told, the report from the New England Journal of Medicine indicated that the number of doctors receiving some form of 'gift' was 94%.
Thoughts?
Monday, April 30, 2007
CMS Speaks: Will Use 3 Decimal CPI-U Values in Near Future
We reached out to CMS early in March of 2007 regarding the Bureau of Labor Statistics (BLS) changing of the CPI-U Values to 3 decimal places. On April 19, 2007, CMS replied to our query via e-mail, stating that its technical staff was working changing their systems to accommodate 3 decimal places and hoped to have it implemented by July of 2007. In the interim, CMS will be using rounded values.
While 3 decimals might promote greater accuracy in numbers, statistics, and calculations from BLS’s perspective, it certainly poses unique challenges for both manufacturers and the State Medicaid Programs. Certain GP systems do not automatically allow for CPI-U Values of 3 decimals, while others can be made to handle these numbers.
To that end, CMS should advise manufacturers and the States of their intentions formally and give manufacturers a reasonable amount of time to implement the change. CMS should understand that such a change is anything but simple—it’s not like flipping a light switch.
Ideally, manufacturers should have at least 90 days (or one quarter) to implement the change, once CMS announces officially that there will be a change. Manufacturers using systems that require tweaking will need at least that much time.
Will you need to tweak your GP systems? And if so, how much time do you think CMS should allow? What type of guidance would you like to see from CMS?
While 3 decimals might promote greater accuracy in numbers, statistics, and calculations from BLS’s perspective, it certainly poses unique challenges for both manufacturers and the State Medicaid Programs. Certain GP systems do not automatically allow for CPI-U Values of 3 decimals, while others can be made to handle these numbers.
To that end, CMS should advise manufacturers and the States of their intentions formally and give manufacturers a reasonable amount of time to implement the change. CMS should understand that such a change is anything but simple—it’s not like flipping a light switch.
Ideally, manufacturers should have at least 90 days (or one quarter) to implement the change, once CMS announces officially that there will be a change. Manufacturers using systems that require tweaking will need at least that much time.
Will you need to tweak your GP systems? And if so, how much time do you think CMS should allow? What type of guidance would you like to see from CMS?
WELCOME TO THE PHARMA COMPLIANCE BLOG!
Welcome Colleagues & Fellow Bloggers!
Since we at Compliance Implementation Services, LLC (CIS), launched the Pharma Compliance Exchange (PCX), clients and prospective clients have used words like ‘revolutionary,’ ‘Godsend,’ ‘priceless’ and ‘perfect’ to describe it. Through the PCX, GP and Compliance communities have greater and more convenient access to the information and answers they need the most.
In keeping with our commitment to provide unique and innovative consulting products and services, we began exploring ways in which we could offer clients an anonymous forum to discuss their GP and Compliance issues with their industry counterparts. We soon realized the need for a dynamic ‘information exchange’ between the members of these groups.
Enter The Pharma Compliance Blog (PCB)!
The PCB is a dynamic forum in which the GP and Compliance communities can exchange information and discuss issues in a professional and anonymous environment each and every day.
We at CIS are committed to providing the pharmaceutical community with a forum where users can discuss issues, pose questions, get the latest news and information, and request information from their counterparts anonymously. We believe that the free flow of information will better enable users to make informed decisions regarding business operations and compliance issues. We urge you all to post on your own and to send in possible topics or forums for discussion. Also, if you spot or learn anything outside of the blog that we should be sharing --- let us know! We encourage creativity --- rather, we crave creativity!
For more information on posting Blogs or responding to Blogs and/or comments contained on this site, please refer to the Terms of Service and Policies at http://www.blogger.com/. Most of these are fairly obvious rules—you cannot use the site for illegal purposes, you must abide by copyright laws, you must refrain from publishing hate content, etc.—but please review these for your own edification.
Each user must determine if he/she wishes to provide personal information. End users—not CIS—are ultimately responsible for maintaining their anonymity and the anonymity of their respective companies.
Further, CIS wishes to keep this forum as professional as possible. Therefore, personal attacks, derogatory remarks directed at other users, proselytizing, and other like posting or commentary is entirely inappropriate. Again, we ask that you use common sense when posting to the site; treat others with respect, courtesy, and in the manner in which you would like to be treated.
CIS will monitor the PCB to ensure that discussions remain professional and appropriate and will take action where necessary to preserve that atmosphere. CIS, therefore, reserves the right to remove users engaged in inappropriate activity. We also encourage you to contact us directly if you run into any problems with other users.
Finally, if you would like further information or compliance assistance, please do not hesitate to contact Steven Moore or Brian O’Rourke at CIS via telephone at 610-565-8007, or via e-mail at stevenmoore@cis-partners.com or brianorourke@cis-partners.com.
Now go on and get blogging bloggers --- and start learning!!!
The Pharma Compliance Blog: Your Space. For Your Space.
Since we at Compliance Implementation Services, LLC (CIS), launched the Pharma Compliance Exchange (PCX), clients and prospective clients have used words like ‘revolutionary,’ ‘Godsend,’ ‘priceless’ and ‘perfect’ to describe it. Through the PCX, GP and Compliance communities have greater and more convenient access to the information and answers they need the most.
In keeping with our commitment to provide unique and innovative consulting products and services, we began exploring ways in which we could offer clients an anonymous forum to discuss their GP and Compliance issues with their industry counterparts. We soon realized the need for a dynamic ‘information exchange’ between the members of these groups.
Enter The Pharma Compliance Blog (PCB)!
The PCB is a dynamic forum in which the GP and Compliance communities can exchange information and discuss issues in a professional and anonymous environment each and every day.
We at CIS are committed to providing the pharmaceutical community with a forum where users can discuss issues, pose questions, get the latest news and information, and request information from their counterparts anonymously. We believe that the free flow of information will better enable users to make informed decisions regarding business operations and compliance issues. We urge you all to post on your own and to send in possible topics or forums for discussion. Also, if you spot or learn anything outside of the blog that we should be sharing --- let us know! We encourage creativity --- rather, we crave creativity!
For more information on posting Blogs or responding to Blogs and/or comments contained on this site, please refer to the Terms of Service and Policies at http://www.blogger.com/. Most of these are fairly obvious rules—you cannot use the site for illegal purposes, you must abide by copyright laws, you must refrain from publishing hate content, etc.—but please review these for your own edification.
Each user must determine if he/she wishes to provide personal information. End users—not CIS—are ultimately responsible for maintaining their anonymity and the anonymity of their respective companies.
Further, CIS wishes to keep this forum as professional as possible. Therefore, personal attacks, derogatory remarks directed at other users, proselytizing, and other like posting or commentary is entirely inappropriate. Again, we ask that you use common sense when posting to the site; treat others with respect, courtesy, and in the manner in which you would like to be treated.
CIS will monitor the PCB to ensure that discussions remain professional and appropriate and will take action where necessary to preserve that atmosphere. CIS, therefore, reserves the right to remove users engaged in inappropriate activity. We also encourage you to contact us directly if you run into any problems with other users.
Finally, if you would like further information or compliance assistance, please do not hesitate to contact Steven Moore or Brian O’Rourke at CIS via telephone at 610-565-8007, or via e-mail at stevenmoore@cis-partners.com or brianorourke@cis-partners.com.
Now go on and get blogging bloggers --- and start learning!!!
The Pharma Compliance Blog: Your Space. For Your Space.
Subscribe to:
Posts (Atom)
